Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umair Majeed

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
JCO Precision Oncology|March 25, 2026
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal CarcinomaFares Jamal, Oudai Sahwan, Seyi Abidoye, et al.
Frontiers in Oncology|January 27, 2022
Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall SurvivalGehan Botrus, Pedro Luiz Serrano Uson Junior, Puneet Raman, et al.
American Journal of Hematology|June 17, 2022
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018)Karan Seegobin, Zhuo Li, Muhamad Alhaj Moustafa, et al.
Future Oncology (London, England)|June 11, 2024
COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTCNilofer Azad, Zishuo Hu, Ilyas Sahin, et al.
JAMA Network Open|September 12, 2025
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary TumorsHimil Mahadevia, Umair Majeed, Jaydeepbhai Patel, et al.
JCO Oncology Practice|June 14, 2021
Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening StrategiesZhuoer Xie, Antoine N Saliba, Jithma Abeykoon, et al.
JCO Precision Oncology|June 6, 2022
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based ChemotherapyPedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2022
Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumabRobert W Gao, Courtney N Day, Nathan Y Yu, et al.
JCO Precision Oncology|July 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract CancersPriyanshi Shah, Anina Peersen, Vaibhav Sahai, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
JCO Precision Oncology|March 25, 2026
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal CarcinomaFares Jamal, Oudai Sahwan, Seyi Abidoye, et al.
Frontiers in Oncology|January 27, 2022
Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall SurvivalGehan Botrus, Pedro Luiz Serrano Uson Junior, Puneet Raman, et al.
American Journal of Hematology|June 17, 2022
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018)Karan Seegobin, Zhuo Li, Muhamad Alhaj Moustafa, et al.
Future Oncology (London, England)|June 11, 2024
COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTCNilofer Azad, Zishuo Hu, Ilyas Sahin, et al.
JAMA Network Open|September 12, 2025
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary TumorsHimil Mahadevia, Umair Majeed, Jaydeepbhai Patel, et al.
JCO Oncology Practice|June 14, 2021
Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening StrategiesZhuoer Xie, Antoine N Saliba, Jithma Abeykoon, et al.
JCO Precision Oncology|June 6, 2022
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based ChemotherapyPedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2022
Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumabRobert W Gao, Courtney N Day, Nathan Y Yu, et al.
JCO Precision Oncology|July 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract CancersPriyanshi Shah, Anina Peersen, Vaibhav Sahai, et al.
Pageof 5